共 12 条
- [1] NF-κB inducing kinase is a therapeutic target for systemic lupus erythematosus[J]. NATURE COMMUNICATIONS, 2018, 9Brightbill, Hans D.Suto, EricBlaquiere, NicoleRamamoorthi, NandhiniSujatha-Bhaskar, SwathiGogol, Emily B.Castanedo, Georgette M.Jackson, Benjamin T.Kwon, Youngsu C.Haller, SusanLesch, JustinBents, KarinEverett, ChristineKohli, Pawan BirLinge, SandraChristian, LauraBarrett, KathyJaochico, AllanBerezhkovskiy, Leonid M.Fan, Peter W.Modrusan, ZoraVeliz, KelliTownsend, Michael J.DeVoss, JasonJohnson, Adam R.Godemann, RobertLee, Wyne P.Austin, Cary D.McKenzie, Brent S.Hackney, Jason A.Crawford, James J.Staben, Steven T.Ismaili, Moulay H. AlaouiWu, Lawren C.Ghilardi, Nico
- [2] The IL32/BAFF axis supports prosurvival dialogs in the lymphoma ecosystem and is disrupted by NIK inhibition[J]. HAEMATOLOGICA, 2022, 107 (12) : 2905 - 2917Decombis, SalomePapin, AntoninBellanger, CelineSortais, ClaraDousset, ChristelleLe Bris, YannickRiveron, ThiphanieBlandin, StephanieHulin, PhilippeTessoulin, BenoitRouel, MathieuLe Gouill, StevenMoreau-Aubry, AgnesPellat-Deceunynck, CatherineChiron, David
- [3] Regulation of Bcl-XL by non-canonical NF-κB in the context of CD40-induced drug resistance in CLL[J]. CELL DEATH AND DIFFERENTIATION, 2021, 28 (05) : 1658 - 1668Haselager, MarcoThijssen, RachelWest, ChristopherYoung, LouiseVan Kampen, RoelWillmore, ElaineMackay, SimonKater, ArnonEldering, Eric
- [4] Changes in Bcl-2 members after ibrutinib or venetoclax uncover functional hierarchy in determining resistance to venetoclax in CLL[J]. BLOOD, 2020, 136 (25) : 2918 - 2926Haselager, Marco, VKielbassa, Karolineter Burg, JohannaBax, Danique J. C.Fernandes, Stacey M.Borst, JannieTam, ConstantineForconi, FrancescoChiodin, GiorgiaBrown, Jennifer R.Dubois, JulieKater, Arnon P.Eldering, Eric
- [5] Anti-BAFF-R antibody VAY-736 demonstrates promising preclinical activity in CLL and enhances effectiveness of ibrutinib[J]. BLOOD ADVANCES, 2019, 3 (03) : 447 - 460McWilliams, Emily M.Lucas, Christopher R.Chen, TimothyHarrington, Bonnie K.Wasmuth, RonniCampbell, AmandaRogers, Kerry A.Cheney, Carolyn M.Mo, XiaokuiAndritsos, Leslie A.Awan, Farrukh T.Woyach, JenniferCarson, William E., IIIButchar, JonathanTridandapani, SusheelaHertlein, ErinCastro, Carlos E.Muthusamy, NatarajanByrd, John C.
- [6] CSF1R and BTK inhibitions as novel strategies to disrupt the dialog between mantle cell lymphoma and macrophages[J]. LEUKEMIA, 2019, 33 (10) : 2442 - 2453Papin, AntoninTessoulin, BenoitBellanger, CelineMoreau, AnneLe Bris, YannickMaisonneuve, HerveMoreau, PhilippeTouzeau, CyrilleAmiot, MartinePellat-Deceunynck, CatherineLe Gouill, StevenChiron, David
- [7] Targeting NF-κB-Inducing Kinase (NIK) in Immunity, Inflammation, and Cancer[J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (22) : 1 - 19Pflug, Kathryn M.Sitcheran, Raquel
- [8] Differential macrophage programming in the tumor microenvironment[J]. TRENDS IN IMMUNOLOGY, 2012, 33 (03) : 119 - 126Ruffell, BrianAffara, Nesrine I.Coussens, Lisa M.
- [9] Targeting BAFF and APRIL in systemic lupus erythematosus and other antibody-associated diseases[J]. INTERNATIONAL REVIEWS OF IMMUNOLOGY, 2017, 36 (01) : 3 - 19Samy, EileenWax, StephenHuard, BertrandHess, HenrySchneider, Pascal
- [10] CD40 signaling instructs chronic lymphocytic leukemia cells to attract monocytes via the CCR2 axis[J]. HAEMATOLOGICA, 2017, 102 (12) : 2069 - 2076van Attekum, Martijn H. A.van Bruggen, Jaco A. C.Slinger, ErikLebre, M. CristinaReinen, EmilieKersting, SabinaEldering, EricKater, Arnon P.